Casey Lynch - Nov 18, 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
Chief Executive Officer, Director
Signature
/s/ Caryn Gordon McDowell, as Attorney-in-Fact for Casey C. Lynch
Stock symbol
QNCX
Transactions as of
Nov 18, 2021
Transactions value $
$27,600
Form type
4
Date filed
11/19/2021, 07:58 PM
Previous filing
May 12, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $27.6K +60K +120.25% $0.46 110K Nov 18, 2021 Direct
holding QNCX Common Stock 979K Nov 18, 2021 By the Zachary and Casey Lynch Living Trust dated February 24, 2009 F1
holding QNCX Common Stock 91.9K Nov 18, 2021 By The Casey C. Lynch 2019 Annuity Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (Right to Buy) Options Exercise $0 -60K -72.15% $0.00 23.2K Nov 18, 2021 Common Stock 60K $0.46 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Casey C. Lynch is a trustee of the Zachary and Casey Lynch Living Trust dated February 24, 2009, and shares voting and dispositive power with one other trustee with respect to the shares held of record by the Zachary and Casey Lynch Living Trust dated February 24, 2009.
F2 Casey C. Lynch is the trustee of The Casey C. Lynch 2019 Annuity Trust, and holds sole voting and dispositive power with respect to the shares held of record by The Casey C. Lynch 2019 Annuity Trust.
F3 The option vested as to 1/48th of the shares on July 13, 2017, and the remaining shares vested in equal monthly installments from August 13, 2017 and ended on June 13, 2021.
F4 The expiration date of this option was erroneously reported as 06/0/1/2022 on the Form 3 filed on May 8, 2019.